293 results on '"Mancuso, Salvatrice"'
Search Results
2. Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study
3. Bone damage and health-related quality of life in Hodgkin lymphoma survivors: closing the gaps
4. Thrombotic Risk and Calculated Whole Blood Viscosity in a Cohort of Patients With New Diagnosis of Multiple Myeloma
5. Patients' Perception of Usability and Utility of a Digital Health Tool for Electronic Patient-Reported Outcomes Monitoring in Real-Life Hematology Practice: Evidence from the Gimema-Alliance Platform
6. EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas
7. Buffy coat-derived platelets cryopreserved using a new method: Results from a pivotal clinical trial on thrombocytopenic patients with acute leukaemia
8. A Multicentric Castleman disease associated with mixed warm and cold antibody–mediated AHA responsive to siltuximab
9. Hemophagocytic lymphohistiocytosis secondary to histoplasmosis: A case report in a patient with AIDS and recent SARS-CoV-2 infection and minireview
10. Molecular-Biology-Driven Frontline Treatment for Chronic Lymphocytic Leukemia: A Network Meta-Analysis of Randomized Clinical Trials
11. A Multicentric Castleman Disease Associated with Mixed Warm and Cold Antibody-Mediated AHA Responsive to Siltuximab.
12. Molecular-Biology-Driven Frontline Treatment for Chronic Lymphocytic Leukemia: A Network Meta-Analysis of Randomized Clinical Trials
13. Calculated Whole Blood Viscosity and Albumin/Fibrinogen Ratio in Patients with a New Diagnosis of Multiple Myeloma: Relationships with Some Prognostic Predictors
14. Hemophagocytic Lymphohistiocytosis Secondary to Histoplasmosis in an AIDS Patient with Recent SARS-CoV-2 Infection and Minireview
15. Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia
16. Immunosenescence and lymphomagenesis
17. Author response for 'Host-related factors and cancer: Malnutrition and non-Hodgkin lymphoma'
18. Host‐related factors and cancer: Malnutrition and non‐Hodgkin lymphoma
19. Effects of B-Cell Lymphoma on the Immune System and Immune Recovery after Treatment: The Paradigm of Targeted Therapy
20. Familial essential thrombocythemia: 6 cases from a mono‐institutional series
21. Clinical Phenotype and Response to Different Lines of Therapy in Elderly with Immune Thrombocytopenia: A Retrospective Study
22. High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations
23. The difference of free light chains as a predictor of kidney damage in patients with Multiple Myeloma
24. Thrombotic risk in paroxysmal nocturnal hemoglobinuria-like (PNH-like) phenotype
25. Comparison between whole blood viscosity measured and calculated in subjects with monoclonal gammopathy of undetermined significance and in patients with multiple myeloma: Re-evaluation of our survey
26. Clinical Utility and Physician Perceptions of a Digital Platform for Electronic Patient-Reported Outcomes Monitoring in Patients with Hematologic Malignancies in Real-World Practice
27. The Antineoplastic Role of STAT5 Inhibition in BCRABL1-Positive Cells Exposed to Pimozide Alone and in Combination with Dasatinib and Ponatinib
28. Triple-negativity identifies a subgroup of patients with better overall survival in essential thrombocythemia
29. MRD Monitoring By Euroclonality IGH Based NGS Approach Predicts Outcome in Follicular Lymphoma Patients Lacking a Conventional BCL2::IGH Marker: A Substudy from the Fondazione Italiana Linfomi (FIL) FOLL12 Trial
30. Familial Essential Thrombocytemia : 6 cases from a mono-institutional series.
31. Cardiovascular Issues in Tyrosine Kinase Inhibitors Treatments for Chronic Myeloid Leukemia: A Review
32. Paroxysmal nocturnal hemoglobinuria-like phenotype and thrombotic risk in several clinical disorders
33. Human Immunodeficiency Virus Seroprevalence and Condom Use Among Female Sex Workers in Italy
34. Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL)
35. Synthesis and induction of G0–G1 phase arrest with apoptosis of 3,5-dimethyl-6-phenyl-8-(trifluoromethyl)-5,6-dihydropyrazolo[3,4- f][1,2,3,5]tetrazepin-4(3 H)-one
36. Coexistence of Von Willebrand disease and gastrointestinal stromal tumor (G.I.S.T): Case report of a rare and challenge association
37. Prevention of venous thromboembolic events occurring in myeloma patients treated with second-generation novel agents
38. Clinical Phenotype and Response to Different Lines of Therapy in Elderly with Immune Thrombocytopenia: A Retrospective Study
39. Isolated Nodal TBC Reactivation in a Patient with Post-Thrombocythemia Myelofibrosis Treated with Ruxolitinib: Case Report and Review of the Literature
40. Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients
41. Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study
42. Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study
43. The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors
44. Cardiovascular Risk in Polycythemia Vera: Thrombotic Risk and Survival: Can Cytoreductive Therapy Be Useful in Patients with Low-Risk Polycythemia Vera with Cardiovascular Risk Factors?
45. CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL
46. The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep
47. T Cell Large Granular Lymphocytic Leukemia in Association with Sjögrenʼs Syndrome
48. Evaluation of Bone Marrow CD8+ tissue-Resident Memory T Cells in Multiple Myeloma
49. Combined Point of Care Tools Are Able to Improve Treatment Adherence and Health-Related Quality of Life in Patients with Severe Hemophilia: An Observational Prospective Study
50. Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.